CONCOR

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Germany, Hong Kong SAR China, Israel, Italy, Mexico, Nigeria, Poland, Romania, Singapore, South Africa, Turkey.

Active ingredients

The drug CONCOR contains one active pharmaceutical ingredient (API):

1	Bisoprolol UNII UR59KN573L - BISOPROLOL FUMARATE
	Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity.
	Read more about Bisoprolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CONCOR Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB07	Bisoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525403003110413, 525403004117411, 525403005113411, 525403006111410, 525403007116416, 525403008112414, 525416060047403, 525416060047503, 525416060047603, 525416060047703, 525416060047803, 525416060047903, 525416060048003, 525416060048103
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02091573, 02091751
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	20.533-1-06-03, 20.534-1-06-03, 28239-1-08-07, 29494-1-11-10
EE	Ravimiamet	1225662
HK	Department of Health Drug Office	29917, 48662
HR	Agencija za lijekove i medicinske proizvode	HR-H-148909302, HR-H-747818074
IL	מִשְׂרַד הַבְּרִיאוּת	2757, 2758, 9117, 9118
IT	Agenzia del Farmaco	026573016
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	519M99
NG	Registered Drug Product Database	B4-5411, B4-5412, B4-7135
Switch country to Nigeria in order to find specific presentations of CONCOR
PL	Rejestru Produktów Leczniczych	100015560, 100015576, 100045235, 100099969, 100099975, 100099981, 100099998, 100100000, 100100017, 100256877, 100259628, 100264799, 100264807, 100264871, 100265586, 100288742, 100290331, 100293341, 100293536, 100297646, 100297681, 100299190, 100299697, 100302643, 100306204, 100308918, 100309177, 100310714, 100326997, 100333566, 100333589, 100333595, 100334353, 100335720, 100337038, 100344274, 100344587, 100346126, 100346675, 100352003, 100352032, 100352049, 100352055, 100354982, 100355042, 100355065, 100357325, 100358230, 100360592, 100361380, 100361427, 100362540, 100362591, 100363389, 100363395, 100363521, 100363900, 100363917, 100365566, 100366548, 100370840, 100370923, 100373235, 100374714, 100374789, 100377569, 100384687, 100385267, 100385391, 100386781, 100388633, 100389868, 100391374, 100393700, 100394941, 100394987, 100395165, 100396472, 100400096, 100401405, 100407000, 100408608, 100413087, 100413526, 100414336, 100419629, 100419635, 100422100, 100422130, 100426339, 100427623, 100427860, 100427882, 100434528, 100437745, 100437768, 100438727, 100447666, 100447672, 100450090, 100450110, 100451120, 100451810, 100451827, 100452500, 100453162, 100453170, 100454118, 100455166, 100455173, 100456077, 100459058, 100459814, 100461350, 100462313, 100462762, 100462912, 100464479
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66285001, W66285002, W66286001, W66286002
SG	Health Sciences Authority	01039P, 11349P, 15033P, 15034P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699228090041, 8699228090058
ZA	Health Products Regulatory Authority	V/5.2/303, V/5.2/304